Bluefin Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,500
Closed -$224K 123
2023
Q3
$224K Sell
1,500
-1,900
-56% -$283K 0.02% 76
2023
Q2
$458K Buy
+3,400
New +$458K 0.09% 47
2023
Q1
Sell
-8,340
Closed -$1.35M 129
2022
Q4
$1.35M Sell
8,340
-1,870
-18% -$302K 0.2% 59
2022
Q3
$1.37M Sell
10,210
-1,440
-12% -$193K 0.12% 77
2022
Q2
$1.8M Buy
11,650
+4,390
+60% +$677K 0.2% 61
2022
Q1
$1.18M Sell
7,260
-13,297
-65% -$2.16M 0.11% 83
2021
Q4
$2.78M Sell
20,557
-12,235
-37% -$1.66M 0.19% 84
2021
Q3
$3.54M Buy
32,792
+11,134
+51% +$1.2M 0.35% 47
2021
Q2
$2.44M Buy
21,658
+5,807
+37% +$654K 0.16% 92
2021
Q1
$1.72M Buy
15,851
+3,528
+29% +$382K 0.08% 107
2020
Q4
$1.32M Buy
+12,323
New +$1.32M 0.08% 136
2020
Q3
Sell
-2,875
Closed -$282K 64
2020
Q2
$282K Sell
2,875
-174,564
-98% -$17.1M 0.02% 137
2020
Q1
$13.5M Buy
177,439
+93,595
+112% +$7.13M 1.74% 7
2019
Q4
$7.42M Buy
83,844
+21,710
+35% +$1.92M 0.49% 48
2019
Q3
$4.71M Buy
+62,134
New +$4.71M 0.68% 25
2019
Q2
Hold
0
209
2019
Q1
Sell
-2,200
Closed -$203K 199
2018
Q4
$203K Sell
2,200
-16,866
-88% -$1.56M 0.02% 163
2018
Q3
$1.8M Buy
+19,066
New +$1.8M 0.17% 97
2018
Q1
Sell
-7,960
Closed -$770K 237
2017
Q4
$770K Buy
7,960
+410
+5% +$39.7K 0.05% 153
2017
Q3
$671K Buy
+7,550
New +$671K 0.08% 153
2016
Q4
Sell
-7,183
Closed -$453K 312
2016
Q3
$453K Sell
7,183
-4,754
-40% -$300K 0.02% 150
2016
Q2
$739K Sell
11,937
-698
-6% -$43.2K 0.07% 134
2016
Q1
$722K Sell
12,635
-7,292
-37% -$417K 0.07% 120
2015
Q4
$1.18M Buy
19,927
+1,613
+9% +$95.5K 0.09% 163
2015
Q3
$996K Buy
18,314
+10,486
+134% +$570K 0.06% 181
2015
Q2
$526K Buy
+7,828
New +$526K 0.03% 228
2015
Q1
Sell
-7,399
Closed -$484K 295
2014
Q4
$484K Buy
7,399
+3,225
+77% +$211K 0.03% 268
2014
Q3
$241K Buy
+4,174
New +$241K 0.01% 390
2013
Q3
Sell
-6,183
Closed -$300K 314
2013
Q2
$300K Buy
+6,183
New +$300K 0.03% 305